Home Tags Peptide

Tag: peptide

Avacta and Glythera Partner to Develop Novel, Highly Targeted, Drugs

Avacta Life Sciences, the developer of Affimer® biotherapeutics and research reagents will collaborate with Glythera a developer of advanced, stable conjugation chemistries and novel, ultra-potent...

Europe-wide Training Network Focuses on Targeted Anticancer Drug Development

Currently used anticancer drugs are highly cytotoxic and therapies are often associated with multiple, severe adverse events. For decades drug developers have been working...

Sneaking Medicines Across the Blood-Brain Barrier

Research published in the November 2014 edition of The FASEB Journal, published by the Federation of the American Societies for Experimental Biology, suggests that a very small single domain antibody called FC5 has proven able to cross the blood-brain barrier (BBB). This opens the door to new treatments for a multitude of brain diseases.